查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1421832

週期性发烧综合症市场、份额、规模、趋势、行业分析报告：按适应症、按治疗、按最终用途、按地区、按细分市场、预测，2024-2032年

Periodic Fever Syndrome Market Share, Size, Trends, Industry Analysis Report, By Indication ; By Treatment; By End-Use; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球週期性发烧综合症市场规模预计将达到8.8195亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

越来越多的政府计画致力于增加对不常见疾病的了解，推动了这一领域的成长。 研究活动的增加和快速的技术突破正在导致新药的创造、诊断能力的增强和治疗方法的确立，所有这些都对市场成长做出了重大贡献。 该领域可能会受益于治疗这种疾病的新药的批准。

FMF 是世界上和加拿大最常见的单一自体发炎性疾病，其特征是反覆发作的发烧和涉及浆膜和滑膜的发炎。 它以体染色体隐性方式遗传，在中东和地中海血统的人群中发病率最高，在其他种族群体中患病率各不相同。

隐热蛋白相关週期性症候群 (CAPS) 是一组自体发炎性疾病。 编码冷热蛋白的CIAS1基因中的突变会增加白血球介素I和其他细胞因子的活性，其透过称为Toll样受体的细胞内受体或核甘酸寡聚结构域蛋白连接来活化目标细胞。

Ilaris 是 FDA 批准的第一个也是唯一一个用于治疗 TRAPS、超免疫球蛋白 D 症候群和家族性地中海热的生物製剂。 这三种疾病都属于一种罕见的自体发炎性疾病，称为週期性发烧综合症。 FMF 是最常见的疾病，主要影响东地中海血统的人。 在不同人群中，每 250 人中就有 1 人到 1,000 人中就有 1 人受其影响，其中大多数是儿童。

为了因应 COVID-19，羟氯奎等常用药物的需求显着增加。 由于对 COVID-19 疫苗和治疗的需求，生物製药行业将在未来几年显着增长。 预计这将对週期性发烧综合症市场产生重大影响。 卡那奴单抗最近被批准用于治疗週期性发烧综合征、冷热蛋白相关週期性综合征、週期性发热综合征和全身性幼年系统性关节炎，这可能会支持週期性发热综合征业务的增长。

週期性发烧综合症市场报告亮点

皮质类固醇和非类固醇抗发炎药 (NSAID) 等口服抗发炎药物用于治疗週期性发烧综合征，预计在预测期内将占据重要的市场份额。

由于该地区主要参与者的渗透率不断提高以及对患者护理和监测的重视程度不断提高，北美已成为全球週期性发烧综合征市场的领导者。

目录

第 1 章简介

第 2 章执行摘要

第 3 章研究方法

第 4 章洞察全球週期性发烧症候群市场

  • 週期性发烧综合症市场 - 治疗概况
  • 週期性发烧症候群市场动态
    • 促进因素和机会
      • 基因研究的进展
      • 提高医疗保健专业人员和病患的意识
    • 抑制因素和挑战
      • 有限的患者群体
  • PESTEL 分析
  • 週期性发烧症候群的市场治疗趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球週期性发烧症候群市场：依适应症

  • 主要发现
  • 简介
  • 高免疫球蛋白血症 D 症候群 (HIDS)
  • 家族性地中海热 (FMF)
  • TNF 受体相关週期性症候群 (TRAPS)
  • 隐□林相关週期性综合症
  • 其他

第 6 章全球週期性发烧症候群市场：依最终用途划分

  • 主要发现
  • 简介
  • 医院
  • 零售药局

第 7 章全球週期性发烧症候群市场：依治疗分类

  • 主要发现
  • 简介
  • 口服抗发炎药
  • 非类固醇类抗发炎药 (NSAID)
  • 抗肿瘤坏死因子治疗
  • 他汀类药物
  • 其他

第 8 章全球週期性发烧症候群市场：依地区

  • 主要发现
  • 简介
    • 2019-2032 年週期性发烧症候群市场评估（按地区）
  • 週期性发烧综合症市场 - 北美
    • 北美：週期性发烧症候群市场，依适应症划分，2019-2032 年
    • 北美：週期性发烧症候群市场，依治疗方法，2019-2032 年
    • 北美：週期性发烧症候群市场，依最终用途，2019-2032 年
    • 週期性发烧综合症市场 - 美国
    • 週期性发烧综合症市场 - 加拿大
  • 週期性发烧综合症市场 - 欧洲
    • 欧洲：週期性发烧症候群市场，依适应症划分，2019-2032 年
    • 欧洲：週期性发烧症候群市场，依治疗方法，2019-2032 年
    • 欧洲：週期性发烧症候群市场，依最终用途，2019-2032 年
    • 週期性发烧综合症市场 - 英国
    • 週期性发烧综合症市场 - 法国
    • 週期性发烧综合症市场 - 德国
    • 週期性发烧综合症市场 - 义大利
    • 週期性发烧综合症市场 - 西班牙
    • 週期性发烧综合症市场 - 荷兰
    • 週期性发烧综合症市场 - 俄罗斯
  • 週期性发烧综合症市场 - 亚太地区
    • 亚太地区：週期性发烧症候群市场，依适应症划分，2019-2032 年
    • 亚太地区：週期性发烧症候群市场，依治疗方法，2019-2032 年
    • 亚太地区：週期性发烧综合症市场，依最终用途，2019-2032 年
    • 週期性发烧综合症市场 - 中国
    • 週期性发烧综合症市场 - 印度
    • 週期性发烧综合症市场 - 马来西亚
    • 週期性发烧综合症市场 - 日本
    • 週期性发烧综合症市场 - 印度尼西亚
    • 週期性发烧综合症市场 - 韩国
  • 週期性发烧综合症市场 - 中东和非洲
    • 中东和非洲：按症状划分的週期性发烧综合症市场，2019-2032 年
    • 中东与非洲：週期性发烧症候群市场，依治疗方法，2019-2032 年
    • 中东和非洲：週期性发烧综合症市场，按最终用途，2019-2032 年
    • 週期性发烧综合症市场 - 沙乌地阿拉伯
    • 週期性发烧综合症市场 - 阿拉伯联合大公国
    • 週期性发烧综合症市场 - 以色列
    • 週期性发烧综合症市场 - 南非
  • 週期性发烧综合症市场 - 拉丁美洲
    • 拉丁美洲：週期性发烧症候群市场，依适应症划分，2019-2032 年
    • 拉丁美洲：週期性发烧症候群市场，依治疗方法，2019-2032 年
    • 拉丁美洲：週期性发烧症候群市场，依最终用途，2019-2032 年
    • 週期性发烧综合症市场 - 墨西哥
    • 週期性发烧综合症市场 - 巴西
    • 週期性发烧综合症市场 - 阿根廷

第 9 章竞争态势

  • 扩张与收购分析
    • 扩大
    • 收购
  • 伙伴关係/协作/协议/揭露

第 10 章公司简介

  • Merck & Co Inc
  • Novartis AG
  • Simvastatin
  • Swedish Orphan Biovitrum AB
Product Code: PM4152

The global periodic fever syndrome market size is expected to reach USD 881.95 million by 2032, according to a new study by Polaris Market Research. The report "Periodic fever syndrome Market Share, Size, Trends, Industry Analysis Report, By Indication (Hyper-immunoglobulinemia D syndrome, Familial Mediterranean Fever, TNF Receptor Associated periodic syndrome, Cryopyrin Associated periodic syndrome, Others); By Treatment; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rise of the sector is being aided by a rise in government programs focused on raising public knowledge of uncommon disorders. Increased research activity and quick technical breakthroughs are resulting in the creation of new medications, enhanced diagnostic capabilities, and treatments, all of which contribute significantly to market growth. The sector is likely to benefit from new medication approvals to treat the condition.

FMF is the most prevalent monogenic autoinflammatory illness in the world and in Canada, with repeated, self-limited bouts of fever and inflammation involving serous and synovial membranes. It is inherited in an autosomal recessive manner, and its incidence is highest among groups of Middle Eastern and Mediterranean ancestry, with varying prevalence in other ethnicities.

Cryopyrin-associated periodic syndrome (CAPS) is a series of autoinflammatory illnesses that are connected. Mutations in the CIASl gene, which encodes cryopyrin, induce the enhanced activity of interleukin I and other cytokines, which activate their target cells via an intracellular receptor known as the Toll-like receptor or nucleotide oligomerization domain protein ligation.

Ilaris is the first and only FDA-approved biologic therapy for TRAPS, Hyper immunoglobulin D Syndrome, & Familial Mediterranean Fever. All three disorders are part of a rare category of auto-inflammatory diseases known as Periodic Fever Syndromes. FMF is the most frequent condition, affecting primarily those of Eastern Mediterranean heritage. It affects 1 in 250 to 1 in 1,000 people in various populations, with a majority of them being children.

Commonly used medications, such as hydroxychloroquine, have seen a huge increase in demand for COVID-19 control. Because of the need for vaccinations and treatment medications for COVID-19, the biopharma industry is likely to increase significantly in the future. This, in turn, is projected to have a major influence on the market for periodic fever syndrome. Recently, Canakinumab has been licensed for the treatment of individuals with periodic fever syndrome, cryopyrin-associated periodic syndrome, periodic fever syndrome, and systemic juvenile systemic arthritis which likely boosts the growth of periodic fever syndrome business.

Periodic Fever Syndrome Market Report Highlights

Oral anti-inflammatory medicines such as corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs), among others, are expected to hold a significant market share over the projection period as these are used to treat periodic fever syndrome.

North America is a market leader in the worldwide periodic fever syndrome sector due to the expanding penetration of the region's key companies and the increased emphasis on patient care and monitoring.

The global players include: Merck & Co Inc, Simvastatin, Swedish Orphan Biovitrum AB, and Novartis AG.

Polaris Market Research has segmented the periodic fever syndrome market report based on indication, treatment, end-use and region:

Periodic Fever Syndrome, Indication Outlook (Revenue - USD Million, 2019 - 2032)

  • Hyperimmunoglobulinemia D syndrome
  • Familial Mediterranean Fever (FMF)
  • TNF Receptor Associated Periodic Syndrome (TRAPS)
  • Cryopyrin Associated Periodic Syndrome
  • Others

Periodic Fever Syndrome, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

  • Oral anti-inflammatory drugs
  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • Anti-TNF therapy
  • Statins
  • Others

Periodic fever syndrome, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Retail Pharmacy

Periodic fever syndrome, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Periodic Fever Syndrome Market Insights

  • 4.1. Periodic Fever Syndrome Market - Treatment Snapshot
  • 4.2. Periodic Fever Syndrome Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Genetic Research
      • 4.2.1.2. Growing awareness among healthcare professionals, patients
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited Patient Pool
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Periodic Fever Syndrome Market Treatment Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Periodic Fever Syndrome Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • 5.3. HyperimmunoGlobulinemia D syndrome (HIDS)
    • 5.3.1. Global Periodic Fever Syndrome Market, by HyperimmunoGlobulinemia D syndrome (HIDS), by Region, 2019-2032 (USD Million)
  • 5.4. Familial Mediterranean Fever (FMF)
    • 5.4.1. Global Periodic Fever Syndrome Market, by Familial Mediterranean Fever (FMF), by Region, 2019-2032 (USD Million)
  • 5.5. TNF Receptor-Associated Periodic Syndrome (TRAPS)
    • 5.5.1. Global Periodic Fever Syndrome Market, by TNF Receptor-Associated Periodic Syndrome (TRAPS), by Region, 2019-2032 (USD Million)
  • 5.6. Cryopyrin-Associated Periodic Syndrome
    • 5.6.1. Global Periodic Fever Syndrome Market, by Cryopyrin-Associated Periodic Syndrome, by Region, 2019-2032 (USD Million)
  • 5.7. Others
    • 5.7.1. Global Periodic Fever Syndrome Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Periodic Fever Syndrome Market, by End-Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Global Periodic Fever Syndrome Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 6.4. Retail Pharmacy
    • 6.4.1. Global Periodic Fever Syndrome Market, by Retail Pharmacy, by Region, 2019-2032 (USD Million)

7. Global Periodic Fever Syndrome Market, by Treatment

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • 7.3. Oral anti-inflammatory drugs
    • 7.3.1. Global Periodic Fever Syndrome Market, by Oral anti-inflammatory drugs, By Region, 2019-2032 (USD Million)
  • 7.4. Non-steroidal anti-inflammatory drugs (NSAIDs)
    • 7.4.1. Global Periodic Fever Syndrome Market, by Non-steroidal anti-inflammatory drugs (NSAIDs), By Region, 2019-2032 (USD Million)
  • 7.5. Anti-TNF therapy
    • 7.5.1. Global Periodic Fever Syndrome Market, by Anti-TNF therapy, By Region, 2019-2032 (USD Million)
  • 7.6. Statins
    • 7.6.1. Global Periodic Fever Syndrome Market, by Statins, By Region, 2019-2032 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Periodic Fever Syndrome Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Periodic Fever Syndrome Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Periodic Fever Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Periodic Fever Syndrome Market - North America
    • 8.3.1. North America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.3.2. North America: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.3. North America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.3.4. Periodic Fever Syndrome Market - U.S.
      • 8.3.4.1. U.S.: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.3.5. Periodic Fever Syndrome Market - Canada
      • 8.3.5.1. Canada: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.4. Periodic Fever Syndrome Market - Europe
    • 8.4.1. Europe: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.3. Europe: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.4. Periodic Fever Syndrome Market - UK
      • 8.4.4.1. UK: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.5. Periodic Fever Syndrome Market - France
      • 8.4.5.1. France: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.5.3. France: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.6. Periodic Fever Syndrome Market - Germany
      • 8.4.6.1. Germany: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.7. Periodic Fever Syndrome Market - Italy
      • 8.4.7.1. Italy: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.8. Periodic Fever Syndrome Market - Spain
      • 8.4.8.1. Spain: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.9. Periodic Fever Syndrome Market - Netherlands
      • 8.4.9.1. Netherlands: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.10. Periodic Fever Syndrome Market - Russia
      • 8.4.10.1. Russia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.5. Periodic Fever Syndrome Market - Asia Pacific
    • 8.5.1. Asia Pacific: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.4. Periodic Fever Syndrome Market - China
      • 8.5.4.1. China: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.4.3. China: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.5. Periodic Fever Syndrome Market - India
      • 8.5.5.1. India: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.5.3. India: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.6. Periodic Fever Syndrome Market - Malaysia
      • 8.5.6.1. Malaysia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.7. Periodic Fever Syndrome Market - Japan
      • 8.5.7.1. Japan: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.8. Periodic Fever Syndrome Market - Indonesia
      • 8.5.8.1. Indonesia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.9. Periodic Fever Syndrome Market - South Korea
      • 8.5.9.1. South Korea: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.6. Periodic Fever Syndrome Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.4. Periodic Fever Syndrome Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.5. Periodic Fever Syndrome Market - UAE
      • 8.6.5.1. UAE: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.6. Periodic Fever Syndrome Market - Israel
      • 8.6.6.1. Israel: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.7. Periodic Fever Syndrome Market - South Africa
      • 8.6.7.1. South Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.7. Periodic Fever Syndrome Market - Latin America
    • 8.7.1. Latin America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.4. Periodic Fever Syndrome Market - Mexico
      • 8.7.4.1. Mexico: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.5. Periodic Fever Syndrome Market - Brazil
      • 8.7.5.1. Brazil: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.6. Periodic Fever Syndrome Market - Argentina
      • 8.7.6.1. Argentina: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Merck & Co Inc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Novartis AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Simvastatin
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Swedish Orphan Biovitrum AB
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development

List of Tables

  • Table 1 Global Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 2 Global Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 3 Global Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 4 Periodic Fever Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 6 North America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 7 North America: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 8 U.S.: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 9 U.S.: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 10 U.S.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 11 Canada: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 12 Canada: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 13 Canada: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 14 Europe: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 15 Europe: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 16 Europe: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 17 UK: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 18 UK: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 19 UK: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 20 France: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 21 France: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 22 France: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 23 Germany: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 24 Germany: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 25 Germany: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 26 Italy: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 27 Italy: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 28 Italy: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 29 Spain: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 30 Spain: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 31 Spain: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 32 Netherlands: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 33 Netherlands: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 34 Netherlands: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 35 Russia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 36 Russia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 37 Russia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 41 China: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 42 China: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 43 China: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 44 India: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 45 India: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 46 India: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 47 Malaysia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 48 Malaysia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 49 Malaysia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 50 Japan: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 51 Japan: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 52 Japan: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 53 Indonesia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 54 Indonesia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 55 Indonesia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 56 South Korea: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 57 South Korea: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 58 South Korea: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 65 UAE: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 66 UAE: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 67 UAE: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 68 Israel: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 69 Israel: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 70 Israel: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 71 South Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 72 South Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 73 South Africa: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 74 Latin America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 75 Latin America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 76 Latin America: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 77 Mexico: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 78 Mexico: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 79 Mexico: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 80 Brazil: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 81 Brazil: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 82 Brazil: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 83 Argentina: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 84 Argentina: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 85 Argentina: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Periodic Fever Syndrome Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by End-Use
  • Figure 7. Global Periodic Fever Syndrome Market, by End-Use, 2022 & 2032 (USD Million)
  • Figure 8. Market by Indication
  • Figure 9. Global Periodic Fever Syndrome Market, by Indication, 2022 & 2032 (USD Million)
  • Figure 10. Market by Treatment
  • Figure 11. Global Periodic Fever Syndrome Market, by Treatment, 2022 & 2032 (USD Million)
  • Figure 12. Periodic Fever Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Periodic Fever Syndrome Market